Source: PE Hub Network

Corvidia: Sofinnova sells Corvidia Therapeutics for $2.1bn | PE Hub

Sofinnova Partners has sold Corvidia Therapeutics to Novo Nordisk for $2.1 billion.

Read full article »
Corvidia's Competitors | Corvidia's News | Corvidia's Financials
Stay up-to-date with the latest news on Corvidia
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Marc De Garidel's photo - CEO of Corvidia

CEO

Marc De Garidel

CEO Approval Rating

76/100

Read more
Stay up-to-date with the latest news on Corvidia